Company Overview - IM Cannabis Corp. (NASDAQ: IMCC) is a leading medical cannabis company operating in Israel and Germany, focusing on premium cannabis products for medical patients [2][3] - The company aims for sustainable and profitable growth in its key markets, leveraging a data-driven approach and a globally sourced product supply chain [2] Operational Highlights - The IMC ecosystem in Israel includes subsidiaries that import and distribute cannabis, operate medical cannabis retail pharmacies, and manage online platforms and distribution centers [3] - In Germany, IMC operates through Adjupharm GmbH, distributing cannabis to pharmacies for medical patients [3] Upcoming Financial Reporting - IM Cannabis Corp. will report its operational and financial results for the second quarter of 2025 on August 12, 2025, before the market opens [1]

________________________ Akanda Corp. As filed with the Securities and Exchange Commission on February 20, 2024 Registration No. 333-_______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (Exact name of Registrant as specified in its charter) ________________________ | | | (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificat ...